These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6730442)

  • 1. [Increased effectiveness of influenza prevention vaccination by using levamisole].
    Pavlishin VV; Savtsova ZD; Giulling EV
    Vopr Virusol; 1984; 29(2):248-50. PubMed ID: 6730442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunization with a complex preparation: a new method of influenza prevention. The basis for using a complex preparation for preventing influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV; Shapiro NI; Aksenov OA
    Vopr Virusol; 1982; 27(2):142-6. PubMed ID: 6178215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cross protection in mice immunized with different anti-influenza preparations].
    Rudenko LG; Sosunov AV; Zykov MP
    Vopr Virusol; 1981; (6):706-9. PubMed ID: 7336695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined use of interferon inducers and recombinant influenza viruses for protection from the disease].
    Podcherniaeva RIa; Shchipanova MV; Nosik NN; Ershov FI; L'vov DK
    Vopr Virusol; 1984; 29(2):173-5. PubMed ID: 6203227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanisms of the formation of heterologous resistance in peroral immunization with a complex anti-influenza preparation].
    Markevich NA; Maslennikova II; Pokrovskaia EE; Osipova MV; Ispolatova AV
    Vestn Ross Akad Med Nauk; 1996; (1):51-4. PubMed ID: 8907427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effect of oral immunization against influenza with a live vaccine in mice].
    Noack K; Bergmann KC; Pohl WD; Tischner H; Luther P
    Z Erkr Atmungsorgane; 1985; 164(1):79-82. PubMed ID: 3984402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunomodulating action of levamisole in influenzal infection in mice].
    Volgarev AP; Poliak RIa
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):88-91. PubMed ID: 6485672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of the effectiveness of inactivated chromatographic influenza vaccine prepared from the native and recombinant strains of influenza virus].
    Rozaeva NR; Bichurina MA; Fridman EA
    Vopr Virusol; 1989; 34(6):738-41. PubMed ID: 2633468
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.
    Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B
    Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of equine influenza vaccines including tetanus toxoid of combined vaccines].
    Bommeli W; Kihm U; Löhrer J; Fey H
    Schweiz Arch Tierheilkd; 1980 Jan; 122(1):27-37. PubMed ID: 7384775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemagglutinin antigenic determinants of Hong Kong influenza viruses and their role in creating resistance to influenza infection].
    Platonova AL; Isaeva EI; Rovnova ZI; Kosiakov PN
    Vopr Virusol; 1980; (6):712-5. PubMed ID: 6164164
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant.
    Ozaki T; Yauchi M; Xin KQ; Hirahara F; Okuda K
    Viral Immunol; 2005; 18(2):373-80. PubMed ID: 16035949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
    Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
    Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potentials for immunization against influenza using liposome-incorporated viral surface antigens].
    Burducea O; Marcheş F; Duţu C; Grancea C; Nicolau A; Păun C
    Virologie; 1989; 40(2):97-106. PubMed ID: 2781727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chitosan as an adjuvant for parenteral inactivated influenza vaccines].
    Gendon IuZ; Markushin SG; Krivtsov GG; Akopova II
    Vopr Virusol; 2008; 53(5):14-9. PubMed ID: 19069787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.